
内科理论与实践››2022,Vol. 17››Issue (01): 78-83.doi:10.16138/j.1673-6087.2022.01.015
收稿日期:2021-06-29出版日期:2022-02-28发布日期:2022-07-25通讯作者:陈慎 E-mail:1943900815@qq.com基金资助:
QIU Liwen1, XU Yiming1, ZHANG Yin1, SHEN Honghua1, CHEN Shen2(
)
Received:2021-06-29Online:2022-02-28Published:2022-07-25Contact:CHEN Shen E-mail:1943900815@qq.com摘要:
目的:评价抗阻联合有氧训练对老年慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)患者运动能力的疗效。方法:共80例老年稳定期COPD患者入选本研究,随机分入联合训练组和有氧训练组,分别给予有氧训练和(或)抗阻训练,共12周。最终完成有氧训练35例,联合训练37例。2组患者在治疗前后及随访3个月后,均进行肺功能、动脉血气分析、运动能力、生活质量、焦虑抑郁心理状态的评定,并对相关结果进行对比分析。结果:在治疗后,联合训练组3 min步行距离(3 minutes walking distance,3MWD)、氧分压(partial pressure of oxygen,PaO2)、体质量指数(body mass index,BMI)、圣乔治呼吸问卷(St George’s respiratory questionnaire, SGRQ)评分均较治疗前明显改善(均P<0.05);3 MWD 及SGRQ评分在随访3个月后较其自身基线比较差异也有统计学意义(均P<0.05);有氧训练组在3 MWD、PaO2较治疗前明显改善(均P<0.05)。治疗后及随访3个月后,联合训练组在BMI、3 MWD 及SGRQ评分均较有氧训练组有明显改善(均P<0.05);治疗后联合训练组抑郁状态较有氧训练组改善,但3个月后焦虑状态较有氧训练组严重(P<0.05);2组患者在肺功能、动脉血气分析、心率、COPD评估测试方面比较,差异无统计学意义(均P>0.05)。结论:对稳定期COPD的老年患者也能进行抗阻联合有氧训练,12周康复训练能明显改善其运动能力、生活质量及BMI,并且运动能力的疗效持续3个月以上,但对于肺功能影响不大。
中图分类号:
仇丽雯, 许轶明, 张音, 沈宏华, 陈慎. 抗阻联合有氧训练对老年慢性阻塞性肺疾病患者运动能力的疗效[J]. 内科理论与实践, 2022, 17(01): 78-83.
QIU Liwen, XU Yiming, ZHANG Yin, SHEN Honghua, CHEN Shen. Evaluate therapeutic efficacy of resistance training and aerobic training for gerontal patients with chronic obstructive pulmonary disease[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 78-83.
表1
有氧训练组和联合训练组的基线水平比较[$\bar{x} \pm s$/n(%)]
| 参数 | 有氧训练组 (n=35) |
联合训练组 (n=37) |
P |
|---|---|---|---|
| 年龄(岁) | 75.6±7.9 | 76.6±5.7 | 0.344 |
| 男性 | 20(57.1) | 22(59.5) | 0.842 |
| BMI(kg/m2) | 21.78±2.37 | 22.10±2.26 | 0.549 |
| 吸烟[n(%)] | 10(28.6) | 15(40.5) | 0.286 |
| 吸烟量(年支) | 407±65 | 401±57 | 0.821 |
| 高血压[n(%)] | 23(65.7) | 22(59.5) | 0.584 |
| 2型糖尿病[n(%)] | 6(17.1) | 8(21.6) | 0.631 |
| 冠心病[n(%)] | 8(22.9) | 10(27.0) | 0.683 |
| FVC(L) | 3.70±0.44 | 3.77±0.45 | 0.573 |
| FEV1(L) | 2.40±0.38 | 2.50±0.42 | 0.284 |
| FEV1/FVC(%) | 0.64±0.05 | 0.66±0.05 | 0.214 |
| PaO2(mmHg) | 62.69±8.48 | 61.22±8.93 | 0.459 |
| PaCO2(mmHg) | 46.94±4.96 | 47.81±7.59 | 0.570 |
| 心率(次/min) | 78.97±10.37 | 79.51±12.87 | 0.845 |
| CAT(分) | 9.86±2.50 | 9.70±3.78 | 0.840 |
| SGRQ(分) | 15.46±7.75 | 16.65±7.77 | 0.520 |
| 3MWD(m) | 116.66±44.78 | 117.62±41.97 | 0.925 |
| HAMA(分) | 4.00±3.27 | 5.05±3.24 | 0.174 |
| HRSD(分) | 9.11±3.72 | 8.03±3.48 | 0.205 |
表2
有氧训练组和联合训练组康复干预后的各参数比较($\bar{x} \pm s$)
| 参数 | 有氧训练组 (n=35) |
联合训练组 (n=37) |
P |
|---|---|---|---|
| BMI(kg/m2) | |||
| 基线 | 21.78±2.37 | 22.10±2.26 | 0.549 |
| 治疗12周末 | 22.05±2.24 | 23.15±1.831) | 0.025 |
| 随访3月末 | 21.51±2.30 | 22.80±2.17 | 0.017 |
| FVC(L) | |||
| 基线 | 3.70±0.44 | 3.77±0.45 | 0.573 |
| 治疗12周末 | 3.71±0.44 | 3.77±0.44 | 0.561 |
| 随访3月末 | 3.76±0.34 | 3.84±0.41 | 0.395 |
| FEV1(L) | |||
| 基线 | 2.40±0.38 | 2.50±0.42 | 0.284 |
| 治疗12周末 | 2.41±0.37 | 2.53±0.43 | 0.202 |
| 随访3月末 | 2.51±0.37 | 2.60±0.40 | 0.331 |
| FEV1/FVC(%) | |||
| 基线 | 0.64±0.05 | 0.66±0.05 | 0.214 |
| 治疗12周末 | 0.65±0.05 | 0.67±0.05 | 0.106 |
| 随访3月末 | 0.66±0.06 | 0.67±0.05 | 0.525 |
| PaO2(mmHg) | |||
| 基线 | 62.69±8.48 | 61.22±8.93 | 0.459 |
| 治疗12周末 | 68.67±7.841) | 70.89±7.881) | 0.238 |
| PaCO2(mmHg) | |||
| 基线 | 46.94±4.96 | 47.81±7.59 | 0.570 |
| 治疗12周末 | 45.31±4.46 | 47.62±5.65 | 0.059 |
| 心率(次/min) | |||
| 基线 | 78.9±10.4 | 79.5±12.9 | 0.845 |
| 治疗12周末 | 79.3±10.8 | 80.0±13.3 | 0.803 |
| 随访3月末 | 78.6±9.3 | 83.7±13.8 | 0.068 |
| CAT(分) | |||
| 基线 | 9.86±2.50 | 9.70±3.78 | 0.840 |
| 治疗12周末 | 9.51±2.69 | 9.70±2.56 | 0.762 |
| 随访3月末 | 9.74±2.00 | 10.35±2.06 | 0.208 |
| SGRQ(分) | |||
| 基线 | 15.46±7.75 | 16.65±7.77 | 0.520 |
| 治疗12周末 | 14.94±6.45 | 11.75±4.231) | 0.015 |
| 随访3月末 | 15.35±5.88 | 13.02±3.411) | 0.042 |
| 3MWD(m) | |||
| 基线 | 116.66±44.78 | 117.62±41.97 | 0.925 |
| 治疗12周末 | 139.48±44.311) | 161.97±40.721) | 0.028 |
| 随访3月末 | 133.00±51.04 | 155.43±42.321) | 0.046 |
| HAMA(分) | |||
| 基线 | 4.00±3.27 | 5.05±3.24 | 0.174 |
| 治疗12周末 | 3.94±3.01 | 5.16±3.06 | 0.093 |
| 随访3月末 | 4.06±2.10 | 5.43±3.07 | 0.038 |
| HRSD(分) | |||
| 基线 | 9.11±3.72 | 8.03±3.48 | 0.205 |
| 治疗12周末 | 8.86±3.09 | 7.30±3.25 | 0.041 |
| 随访3月末 | 8.29±2.47 | 7.70±3.47 | 0.417 |
| [1] | Nolan CM, Rochester CL. Exercise training modalities for people with chronic obstructive pulmonary disease[J]. COPD, 2019, 16(5-6): 378-389. doi:10.1080/15412555.2019.1637834URL |
| [2] | He GX, Li N, Ren L, et al. Benefits of different intensities of pulmonary rehabilitation for patients with moderate-to-severe COPD according to the GOLD stage[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14: 2291-2304. doi:10.2147/COPD.S214836URL |
| [3] | 任蕾, 李宁, 廖宁, 等. 不同强度康复训练对慢性阻塞性肺疾病患者的疗效评价[J]. 内科理论与实践, 2018, 6(13): 368-374. |
| [4] | 任蕾, 何国霞, 杜井波, 等. 双水平持续气道正压通气在慢性阻塞性肺疾病患者康复运动中的疗效评价[J]. 内科理论与实践, 2015, 3(10): 172-176. |
| [5] | Global Initiative for Chronic Obstructive Lung[EB/OL]. 2019. https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.5-FINAL-04Nov2018_WMS.pdf. |
| [6] | Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation[J]. Am J Respir Crit Care Med, 2013, 188(8): e13-e64. doi:10.1164/rccm.201309-1634STURL |
| [7] | Halding AG, Grov EK. Self-rated health aspects among persons living with chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12: 1163-1172. doi:10.2147/COPD.S129325URL |
| [8] | Spruit MA. Pulmonary rehabilitation[J]. Eur Respir Rev, 2014, 23(131): 55-63. doi:10.1183/09059180.00008013URL |
| [9] | 任蕾, 杜井波, 沈宏华. 老年慢性阻塞性肺疾病康复[M]// 老年病康复指南. 北京: 人民卫生出版社, 2020: 161-173. |
| [10] | Iepsen UW, Munch GD, Rugbjerg M, et al. Effect of endurance versus resistance training on quadriceps muscle dysfunction in COPD: a pilot study[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2659-2669. doi:10.2147/COPD.S114351URL |
| [11] | Güell MR, Cejudo P, Ortega F, et al. Benefits of long-term pulmonary rehabilitation maintenance program in patients with severe chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2017, 195(5): 622-629. doi:10.1164/rccm.201603-0602OCURL |
| [12] | Torres-Sánchez I, Valenza MC, Cebriá I Iranzo MDà, et al. Effects of different physical therapy programs on perceived health status in acute exacerbation of chronic obstructive pulmonary disease patients[J]. Disabil Rehabil, 2018, 40(17): 2025-2031. doi:10.1080/09638288.2017.1323236pmid:28478693 |
| [13] | Matsui H, Jo T, Fushimi K, et al. Outcomes after early and delayed rehabilitation for exacerbation of chronic obstructive pulmonary disease: a nationwide retrospective cohort study in Japan[J]. Respir Res, 2017, 18(1): 68. doi:10.1186/s12931-017-0552-7URL |
| [14] | 刘萍, 王永斌, 高天霖, 等. 综合性肺康复治疗对稳定期慢性阻塞性肺疾病患者运动能力与生存质量影响[J]. 中国康复医学杂志, 2016, 31(8): 884-888. |
| [15] | Covey MK, Collins EG, Reynertson SI, et al. Resistance training as a preconditioning strategy for enhancing aerobic exercise training outcomes in COPD[J]. Respir Med, 2014, 108(8):1141-1152. doi:10.1016/j.rmed.2014.06.001URL |
| [16] | Blindenbach S, Vrancken JWFA, van der Zeijden H, et al. Effects of geriatric COPD rehabilitation on hospital admissions and exercise tolerance: a retrospective observational study[J]. Tijdschr Gerontol Geriatr, 2017, 48(3): 112-120. doi:10.1007/s12439-017-0214-8pmid:28447319 |
| [17] | Berry MJ, Sheilds KL, Adair NE. Comparison of effects of endurance and strength training programs in patients with COPD[J]. COPD, 2018, 15(2): 192-199. doi:10.1080/15412555.2018.1446926URL |
| [18] | Uepsen UW, J rgensen KJ, Ringbaek T, et al. A systematic review of resistance training versus endurance training in COPD[J]. J Cardiopulm Rehabil Prev, 2015, 35(3): 163-172. doi:10.1097/HCR.0000000000000105URL |
| [19] | Rohrer V, Schmidt-Trucksäss A. Impact of exercise, sport and rehabilitation therapy in asthma and COPD[J]. 2014, 71(5): 295-300. |
| [20] | Guilleminault L, Rolland Y, Didier A. Characteristics of non-pharmacological interventions in the elderly with COPD[J]. Rev Mal Respir, 2018, 35(6): 626-641. doi:S0761-8425(18)30156-6pmid:29937313 |
| [21] | Liao WH, Chen JW, Chen X, et al. Impact of resistance training in subjects with COPD: a systematic review and meta-analysis[J]. Respir Care, 2015, 60(8): 1130-1145. doi:10.4187/respcare.03598URL |
| [22] | Puhan MA, Gimeno-Santos E, Cates CJ, et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2016, 12(12): CD005305. |
| [23] | Scoditti E, Massaro M, Garbarino S, et al. Role of diet in chronic obstructive pulmonary disease prevention and treatment[J]. Nutrients, 2019, 11(6): 1357. doi:10.3390/nu11061357URL |
| [24] | Miki K, Maekura R. Nutrition management for COPD[J]. Nihon Rinsho, 2016, 74(5): 801-806. |
| [25] | Itoh M, Tsuji T, Nemoto K, et al. Undernutrition in patients with COPD and its treatment[J]. Nutrients, 2013, 5(4): 1316-1335. doi:10.3390/nu5041316URL |
| [26] | Bone AE, Hepgul N, Kon S, et al. Sarcopenia and frailty in chronic respiratory disease[J]. Chron Respir Dis, 2017, 14(1): 85-99. doi:10.1177/1479972316679664URL |
| [27] | McDonald VM, Gibson PG, Scott HA, et al. Should we treat obesity in COPD? The effects of diet and resistance exercise training[J]. Respirology, 2016, 21(5): 875-882. doi:10.1111/resp.12746pmid:26916174 |
| [28] | Gordon CS, Waller JW, Cook RM, et al. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD[J]. Chest, 2019, 156(1): 80-91. doi:S0012-3692(19)30873-6pmid:31034818 |
| [29] | Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD[J]. Eur Respir Rev, 2014, 23(133): 345-349. doi:10.1183/09059180.00007813pmid:25176970 |
| [30] | Hanania NA, O'Donnell DE. Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14: 1127-1138. doi:10.2147/COPD.S188141URL |
| [31] | Long R, Stracy C, Oliver MC. Nutritional care in chronic obstructive pulmonary disease[J]. Br J Community Nurs, 2018, 23 Suppl 7 :S18-S26. |
| [1] | 张璐璐, 武倩男, 霍如婕, 田新瑞.微RNA-206与肺部疾病的研究进展[J]. 内科理论与实践, 2022, 17(05): 413-417. |
| [2] | 刘礼银, 胡系伟, 杨然.远程医疗在慢性阻塞性肺疾病患者肺康复中的应用价值[J]. 内科理论与实践, 2022, 17(01): 97-101. |
| [3] | 孙娴雯, 李庆云.新型冠状病毒疫情时期的慢性阻塞性肺疾病管理策略——2022版慢性阻塞性肺疾病全球倡议解读[J]. 诊断学理论与实践, 2022, 21(01): 32-37. |
| [4] | 陈梅, 付丛会, 余小萍, 王刚, 徐英.低强度抗阻训练对高龄患者平衡功能和抑郁状态的疗效观察[J]. 内科理论与实践, 2021, 16(05): 344-348. |
| [5] | 李庆云, 孙娴雯.慢性阻塞性肺疾病稳定期管理的几个新视点:2021版 GOLD指南解读[J]. 诊断学理论与实践, 2021, 20(01): 43-47. |
| [6] | 李庆云, 孙娴雯.细化稳定期COPD管理流程和随访策略:2020版GOLD指南解读[J]. 诊断学理论与实践, 2020, 19(04): 354-358. |
| [7] | 杜井波, 沈宏华, 许轶明, 任蕾,.慢性阻塞性肺疾病-阻塞性睡眠呼吸暂停重叠综合征特点分析及康复疗效[J]. 内科理论与实践, 2020, 15(01): 31-37. |
| [8] | 陈燕, 李红鹏, 李诗琪, 张柳, 沈继敏, 李庆云,.冠心病合并阻塞性睡眠呼吸暂停-慢性阻塞性肺疾病重叠综合征1例[J]. 内科理论与实践, 2019, 14(06): 379-380. |
| [9] | 陈宇清, 王铭杰, 朱东, 吕城坚, 陈萍.稳定期Ⅱ、Ⅲ级慢性阻塞性肺疾病患者的气道阻力对呼出气流受限的影响分析[J]. 诊断学理论与实践, 2019, 18(04): 418-422. |
| [10] | 周敏, 张秋蕊.呼吸道、肠道微生物菌群对慢性阻塞性肺疾病的发病及治疗的影响[J]. 诊断学理论与实践, 2019, 18(03): 246-249. |
| [11] | 欧阳松云,.从呼吸调控浅谈阻塞性睡眠呼吸暂停综合征对慢性阻塞性肺疾病的影响[J]. 内科理论与实践, 2019, 14(01): 9-12. |
| [12] | 沈宏华, 许轶明, 王年, 任蕾, 陈锐,.体外膈肌起搏对不同体质量指数慢性阻塞性肺疾病疗效比较[J]. 内科理论与实践, 2019, 14(01): 43-47. |
| [13] | 任蕾, 李宁, 廖宁, 温建军, 沈宏华, 许轶明, 李庆云,.不同强度康复训练对慢性阻塞性肺疾病患者的疗效评价[J]. 内科理论与实践, 2018, 13(06): 368-374. |
| [14] | 杜井波, 沈宏华, 王年, 任蕾,.无创机械通气结合认知康复训练对稳定期重度慢性阻塞性肺疾病合并认知障碍患者的疗效评价[J]. 内科理论与实践, 2018, 13(01): 46-52. |
| [15] | 何权瀛,.对于防控慢性疾病的一些新认识[J]. 内科理论与实践, 2016, 11(04): 227-229. |
| 阅读次数 | ||||||
| 全文 |
|
|||||
| 摘要 |
|
|||||